• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4598975)   Today's Articles (4669)   Subscriber (49356)
Number Citation Analysis
76
Kashiwada T, Azuma A. [The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis]. NIHON NAIKA GAKKAI ZASSHI. THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE 2016;105:970-976. [PMID: 30168687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
77
Kubota Y, Asai K, Murai K, Tsukada YT, Hayashi H, Saito Y, Azuma A, Gemma A, Shimizu W. COPD advances in left ventricular diastolic dysfunction. Int J Chron Obstruct Pulmon Dis 2016;11:649-55. [PMID: 27099482 PMCID: PMC4820215 DOI: 10.2147/copd.s101082] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
78
Koschel D, Cottin V, Maher T, Azuma A, Groves LJ, Hormel P, Sköld M, Tomassetti S. Pirfenidone post-authorization safety registry (PASSPORT) update. Pneumologie 2016. [DOI: 10.1055/s-0036-1572065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
79
Kokuho N, Terasaki Y, Urushiyama H, Terasaki M, Kunugi S, Morimoto T, Azuma A, Usuda J, Gemma A, Eishi Y, Shimizu A. Pulmonary mucosa-associated lymphoid tissue lymphoma associated with pulmonary sarcoidosis: a case report and literature review. Hum Pathol 2016;51:57-63. [PMID: 27067783 DOI: 10.1016/j.humpath.2015.12.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Revised: 11/21/2015] [Accepted: 12/10/2015] [Indexed: 10/22/2022]
80
Bando M, Yamauchi H, Ogura T, Taniguchi H, Watanabe K, Azuma A, Homma S, Sugiyama Y. Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis. Intern Med 2016;55:443-8. [PMID: 26935361 DOI: 10.2169/internalmedicine.55.5272] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
81
Maher T, Cottin V, Azuma A, Groves L, Hormel P, Sköld M, Tomassetti S, Koschel D. P12 Pirfenidone post-authorisation safety registry (PASSPORT) – update and concomitant use of N-acetylcysteine and/or corticosteroids. Thorax 2015. [DOI: 10.1136/thoraxjnl-2015-207770.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
82
Miyazaki Y, Azuma A, Inase N, Taniguchi H, Ogura T, Inoue E, Takeuchi M, Yoshizawa Y, Sugiyama Y, Kudoh S. Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis. Respir Investig 2015;53:288-295. [PMID: 26521106 DOI: 10.1016/j.resinv.2015.05.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2015] [Revised: 05/01/2015] [Accepted: 05/12/2015] [Indexed: 06/05/2023]
83
Kondoh Y, Taniguchi H, Ebina M, Azuma A, Ogura T, Taguchi Y, Suga M, Takahashi H, Nakata K, Sugiyama Y, Kudoh S, Nukiwa T. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan. Respir Investig 2015;53:271-278. [PMID: 26521104 DOI: 10.1016/j.resinv.2015.04.005] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2014] [Revised: 04/25/2015] [Accepted: 04/28/2015] [Indexed: 06/05/2023]
84
Taguchi Y, Ebina M, Hashimoto S, Ogura T, Azuma A, Taniguchi H, Kondoh Y, Suga M, Takahashi H, Nakata K, Sugiyama Y, Kudoh S, Nukiwa T. Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan. Respir Investig 2015;53:279-287. [PMID: 26521105 DOI: 10.1016/j.resinv.2015.06.002] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2015] [Revised: 05/27/2015] [Accepted: 06/13/2015] [Indexed: 06/05/2023]
85
Cottin V, Maher T, Azuma A, Groves L, Hormel P, Sköld M, Tomassetti S, Koschel D. Pirfenidone Post-Authorization Safety Registry (PASSPORT): Update and Concomitant Use of NAC and/or Corticosteroids. Chest 2015. [DOI: 10.1378/chest.2245542] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
86
Atsumi K, Minegishi Y, Takano N, Omori M, Saito Y, Seike M, Azuma A, Kubota K, Gemma A. Crizotinib-induced severe ulcerative esophagitis three years after chemoradiotherapy. Int Cancer Conf J 2015. [DOI: 10.1007/s13691-014-0205-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]  Open
87
Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, Katakami N, Yamashita Y, Sakamoto K, Azuma A, Iwasawa T, Kuwano K, Sakai S, Hiroshima K, Fukuoka J, Yoshimura K, Tada H, Nakagawa K, Nakanishi Y. Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis (West Japan Oncolgy Group 6711L): A Phase II Study. Chest 2015. [DOI: 10.1378/chest.2228629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
88
Inomata M, Nishioka Y, Azuma A. Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis. CORE EVIDENCE 2015;10:89-98. [PMID: 26346347 PMCID: PMC4555978 DOI: 10.2147/ce.s82905] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
89
Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, Johkoh T, Martinez FJ, Myers J, Protzko SL, Richeldi L, Rind D, Selman M, Theodore A, Wells AU, Hoogsteden H, Schünemann HJ. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 2015;192:e3-19. [DOI: 10.1164/rccm.201506-1063st] [Citation(s) in RCA: 1242] [Impact Index Per Article: 138.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]  Open
90
Miura Y, Azuma A. Pirfenidone: an orphan drug for treating idiopathic pulmonary fibrosis. Expert Opin Orphan Drugs 2015. [DOI: 10.1517/21678707.2015.1029453] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
91
Inomata M, Konno S, Azuma A. Historical transition of management of sarcoidosis. World J Respirol 2015;5:4-16. [DOI: 10.5320/wjr.v5.i1.4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2014] [Revised: 01/01/2015] [Accepted: 02/02/2015] [Indexed: 02/06/2023]  Open
92
Enomoto N, Chida K, Suda T, Kaida Y, Taniguchi M, Azuma A, Hayashi H, Ogura T, Kitamura H, Yamaguchi O, Ando M, Sato A, Kudo S. An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter report. CLINICAL RESPIRATORY JOURNAL 2015;10:746-755. [PMID: 25689162 DOI: 10.1111/crj.12281] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2014] [Revised: 01/31/2015] [Accepted: 02/12/2015] [Indexed: 11/29/2022]
93
Bando M, Sugiyama Y, Azuma A, Ebina M, Taniguchi H, Taguchi Y, Takahashi H, Homma S, Nukiwa T, Kudoh S. A prospective survey of idiopathic interstitial pneumonias in a web registry in Japan. Respir Investig 2015;53:51-59. [PMID: 25745849 DOI: 10.1016/j.resinv.2014.11.001] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2014] [Revised: 10/14/2014] [Accepted: 11/06/2014] [Indexed: 06/04/2023]
94
Costabel U, Kolb M, Inoue Y, Hernandez P, Bailes Z, Schlenker-Herceg R, Azuma A. Effect of FEV1/FVC ratio on reduction in FVC decline with nintedanib in the INPULSIS™ trials. Pneumologie 2015. [DOI: 10.1055/s-0035-1544830] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
95
Costabel U, Richeldi L, Azuma A, Inoue Y, Collard HR, Tschoepe I, Stowasser S, Selman M. Pre-specified subgroup analyses of pooled data from the INPULSIS™ trials of nintedanib in idiopathic pulmonary fibrosis. Pneumologie 2015. [DOI: 10.1055/s-0035-1544828] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
96
Costabel U, Inoue Y, Richeldi L, Collard HR, Stowasser S, Tschoepe I, Azuma A. Effect of baseline FVC on decline in lung function with nintedanib: results from the INPULSIS™ trials. Pneumologie 2015. [DOI: 10.1055/s-0035-1544867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
97
Costabel U, Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Cottin V, Flaherty KR, Inoue Y, Kim DS, Kolb M, Noble PW, Selman M, Taniguchi H, Brun M, Girard M, Schlenker-Herceg R, Disse B, Collard HR. Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis: Results of two 52-week, Phase III, randomized, placebo-controlled trials (INPULSIS™). Pneumologie 2015. [DOI: 10.1055/s-0035-1544829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
98
Mochimaru H, Fukuda Y, Azuma A, Osanai K, Saito Y, Mochimaru T, Gemma A. Reconsideration of discrepancies between clinical and histopathological features in acute eosinophilic pneumonia. SARCOIDOSIS, VASCULITIS, AND DIFFUSE LUNG DISEASES : OFFICIAL JOURNAL OF WASOG 2015;31:325-335. [PMID: 25591144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/01/2014] [Accepted: 04/03/2014] [Indexed: 06/04/2023]
99
Crestani B, Cottin V, Costabel U, Inoue Y, Richeldi L, Collard H, Stowasser S, Tschoepe I, Azuma A. Effets du nintédanib sur le déclin de la fonction pulmonaire selon la CVF initiale : résultats des études INPULSIS™. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2014.11.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
100
Azuma A. Searching hidden truth behind clinical trials. Respir Investig 2015;53:1. [PMID: 25542596 DOI: 10.1016/j.resinv.2014.12.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
PrevPage 4 of 16 123451516Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA